The development of pluripotent stem cells

Current Opinion in Genetics and Development

Volumn 22, Issue 5, 2012, Pages 403-408

  Gokhale, Paul J ^a   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL XL; STAGE SPECIFIC EMBRYO ANTIGEN 1;

ADAPTATION; ANTIGEN EXPRESSION; APOPTOSIS; BCL2L1 GENE; BLASTOCYST; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CHROMOSOME 12; CHROMOSOME 17; DNA REPLICATION; ECTODERM; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDODERM; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC VARIABILITY; HM13 GENE; HUMAN; ID1 GENE; INNER CELL MASS; MESODERM; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TERATOMA;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; MICE; NEOPLASTIC STEM CELLS; PLURIPOTENT STEM CELLS; TERATOMA;

IPS;

EID: 84868209681     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2012.07.006     Document Type: Review

References (59)

1. Virchow R. Die krankhaften Greschwulste 1863, vol. 1. August Hirschwald, Berlin.
2. Friedman N.B., Moore R.A. Tumors of the testis. A report of 922 cases. Military Surgery 1946, 99:573-593.
3. Higby D.J., Wallace H.J., Holland J.F. Cis-diamminedichloroplatinum (NSC-119875): a phase I study. Cancer Chemother Rep 1973, 57:459-463.
4. Stevens L.C., Little C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc Natl Acad Sci U S A 1954, 40:1080-1087.
5. Stevens L.C. Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 1967, 38:549-552.
6. Stevens L.C. The biology of teratomas. Adv Morphog 1967, 6:1-31.
7. Kleinsmith L.J., Pierce G.B. Multipotentiality of single embryonal carcinoma cells. Cancer Res 1964, 24:1544-1551.
8. Jacob F. Genetics of the Bacterial Cell 1965, http://www.nobelprize.org/nobel_prizes/medicine/laureates/1965/jacob-lecture.html.
9. Finch B.W., Ephrussi B. Retention of multiple developmental potentialities by cells of a mouse testicular teratocarcinoma during prolonged culture in vitro and their extinction upon hybridization with cells of permanent lines. PNAS 1967, 57:615-621.
10. Martin G.R., Evans M.J. The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture. Cell 1974, 2:163-172.
11. Jakob H., Boon T., Gaillard J., Nicolas J., Jacob F. Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells. Ann Microbiol (Paris) 1973, 124:269-282.
12. Nicolas J.F., Dubois P., Jakob H., Gaillard J., Jacob F. Mouse teratocarcinoma: differentiation in cultures of a multipotential primitive cell line (author's transl). Ann Microbiol (Paris) 1975, 126:3-22.
13. Brinster R.L. Participation of teratocarcinoma cells in mouse embryo development. Cancer Res 1976, 36(Pt 2):3412-3414.
14. Papaioannou V.E., McBurney M.W., Gardner R.L., Evans M.J. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 1975, 258:70-73.
15. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 1975, 72:3585-3589.
16. Papaioannou V.E., Gardner R.L., McBurney M.W., Babinet C., Evans M.J. Participation of cultured teratocarcinoma cells in mouse embryogenesis. J Embryol Exp Morphol 1978, 44:93-104.
17. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
18. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981, 78:7634-7638.
19. Boyse E.A., Old L.J. Some aspects of normal and abnormal cell surface genetics. Annu Rev Genet 1969, 3:269-290.
20. Holden S., Bernard O., Artzt K., Whitmore W.F., Bennett D. Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9). Nature 1977, 270:518-520.
21. Hogan B., Fellous M., Avner P., Jacob F. Isolation of a human teratoma cell line which expresses F9 antigen. Nature 1977, 270:515-518.
22. Artzt K., Dubois P., Bennett D., Condamine H., Babinet C., Jacob F. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc Natl Acad Sci U S A 1973, 70:2988-2992.
23. Solter D., Knowles B.B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A 1978, 75:5565-5569.
24. Andrews P.W., Bronson D.L., Benham F., Strickland S., Knowles B.B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 1980, 26:269-280.
25. Shevinsky L.H., Knowles B.B., Damjanov I., Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982, 30:697-705.
26. Andrews P.W., Goodfellow P.N., Shevinsky L.H., Bronson D.L., Knowles B.B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int J Cancer 1982, 29:523-531.
27. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., Chuva de Sousa Lopes S.M., Howlett S.K., Clarkson A., Ahrlund-Richter L., Pedersen R.A., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
28. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
29. De Los Angeles A., Loh Y.H., Tesar P.J., Daley G.Q. Accessing naive human pluripotency. Curr Opin Genet Dev 2012, 22:272-282.
30. Pera M.F., Tam P.P. Extrinsic regulation of pluripotent stem cells. Nature 2010, 465:713-720.
31. Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C., Dracopoli N.C., Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984, 50:147-162.
32. Thompson S., Stern P.L., Webb M., Walsh F.S., Engstrom W., Evans E.P., Shi W.K., Hopkins B., Graham C.F. Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. J Cell Sci 1984, 72:37-64.
33. Pera M.F., Blasco Lafita M.J., Mills J. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int J Cancer 1987, 40:334-343.
34. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 1984, 103:285-293.
35. Andrews P.W., Nudelman E., Hakomori S., Fenderson B.A. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR). Differentiation 1990, 43:131-138.
36. Andrews P.W., Damjanov I., Berends J., Kumpf S., Zappavigna V., Mavilio F., Sampath K. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 1994, 71:243-251.
37. Enver T., Pera M., Peterson C., Andrews P.W. Stem cell states, fates, and the rules of attraction. Cell Stem Cell 2009, 4:387-397.
38. Tonge P.D., Olariu V., Coca D., Kadirkamanathan V., Burrell K.E., Billings S.A., Andrews P.W. Prepatterning in the stem cell compartment. PLoS One 2010, 5:e10901.
39. Enver T., Soneji S., Joshi C., Brown J., Iborra F., Orntoft T., Thykjaer T., Maltby E., Smith K., Dawud R.A., et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005, 14:3129-3140.
40. Hough S.R., Laslett A.L., Grimmond S.B., Kolle G., Pera M.F. A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PLoS One 2009, 4:pe7708.
41. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
42. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000, 18:399-404.
43. Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007, 25:803-816.
44. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., Meisner L., Zwaka T.P., Thomson J.A., Andrews P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004, 22:53-54.
45. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007, 25:207-215.
46. Hussein S.M., Batada N.N., Vuoristo S., Ching R.W., Autio R., Narva E., Ng S., Sourour M., Hamalainen R., Olsson C., et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471:58-62.
47. Narva E., Autio R., Rahkonen N., Kong L., Harrison N., Kitsberg D., Borghese L., Itskovitz-Eldor J., Rasool O., Dvorak P., et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010, 28:371-377.
48. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Lynch C., Harness J.V., Lee S., Barrero M.J., et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
49. Mayshar Y., Ben-David U., Lavon N., Biancotti J.C., Yakir B., Clark A.T., Plath K., Lowry W.E., Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010, 7:521-531.
50. Amps K., Andrews P.W., Anyfantis G., Armstrong L., Avery S., Baharvand H., Baker J., Baker D., Munoz M.B., Beil S., et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011, 29:1132-1144.
51. Olariu V., Harrison N.J., Coca D., Gokhale P.J., Baker D., Billings S., Kadirkamanathan V., Andrews P.W. Modeling the evolution of culture-adapted human embryonic stem cells. Stem Cell Res 2010, 4:50-56.
52. Desmarais J.A., Hoffmann M.J., Bingham G., Gagou M.E., Meuth M., Andrews P.W. Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress. Stem Cells 2012, 30:1385-1393.
53. Goldring C.E., Duffy P.A., Benvenisty N., Andrews P.W., Ben-David U., Eakins R., French N., Hanley N.A., Kelly L., Kitteringham N.R., et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell 2011, 8:618-628.
54. Andrews P.W., Matin M.M., Bahrami A.R., Damjanov I., Gokhale P., Draper J.S. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 2005, 33(Pt 6):1526-1530.
55. Damjanov I., Andrews P.W. The terminology of teratocarcinomas and teratomas. Nat Biotechnol 2007, 25:1212. discussion 1212.
56. Ben-David U., Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011, 11:268-277.
57. Ben-David U., Mayshar Y., Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 2011, 9:97-102.
58. Pierce G.B. Neoplasms, differentiations and mutations. Am J Pathol 1974, 77:103-118.
59. Shackleton M., Quintana E., Fearon E.R., Morrison S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-829.